In the case of breast cancer, miR-34a was also found to suppress LDHA expression [93, 156], suggesting a potential mechanism for enhancing the sensitivity of breast cancer cells to radiation therapy by inhibiting glucose metabolism. This evidence concerns the gene LDHA and breast carcinoma.